-
FightMND Grant to Fund Phase 2 Study of Investigational Therapy for ALS
Australia-based FightMND has granted about $700,000 to Collaborative Medicinal Development to fund a Phase 2 trial of a potential therapy for ALS. Click here to read more about it.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.